its overlooked benefits for cognition and brain health
Blood 132 , 14731477 (2018)
By reducing the dopamine rush associated with highly rewarding foods, the intense urgency of GLP-1 cravings reduction is achieved
Enrichment with Rpp ( a ) and AtNUDX23 ( b ) was based on comparison of enzyme-treated libraries to no enzyme control libraries
Pioglitazone, a diabetes medication, may benefit selected patients with biopsy-proven NASH, but is also specialist-led and off-label , with potential risks including weight gain, fluid retention, heart failure, and increased fracture risk
GLP1 medications produce the kind of significant, sustained weight loss (15 to 25 percent of body weight in clinical trials) that was previously achievable only through bariatric surgery